Hydro-MRI in Crohn's disease: Appraisal of disease activity

Investigative Radiology

Volumn 35, Issue 7, 2000, Pages 431-437

  Schunk, Klaus ^a   Kern, Annett ^a   Oberholzer, Katja ^a   Kalden, Peter ^a   Mayer, Ine ^a   Orth, Thomas ^a   Wanitschke, Roland ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Bowel opacification; Crohn's disease; Disease activity; Gastrointestinal tract; Hydro MRI; Orally administered contrast

Indexed keywords

GADOLINIUM PENTETATE; MANNITOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BREATH HOLDING; CONTRAST ENHANCEMENT; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0033924076     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200007000-00006     Document Type: Article

References (25)

1. Bernstein CN, Boult IF, Greenberg HM, van der Putten W, Duffy G, Grahame GR. A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn's disease. Gastroenterology 1997;113:390-398.
2. Maglinte DD, Chernish SM, Kelvin FM, O'Connor KW, Hage JP. Crohn disease of the small intestine: Accuracy and relevance of enteroclysis. Radiology 1992;184:541-545.
3. Thoeni RF, Gould RG. Enteroclysis and small bowel series: Comparison of radiation dose and examination time. Radiology 1991;178: 659-662.
4. Kettritz U, Isaacs K, Warshauer DM, Semelka RC. Crohn's disease: Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 1995;21:249-253.
5. Schunk K, Metzmann U, Kersjes W, et al. Verlaufskontrolle des Morbus Crohn: Kann die Hydro-MRT die fraktionierte MagenDarm-Passage ersetzen? Fortschr Röntgenstr 1997;166:389-398.
6. Halligan S, Saunders B, Williams C, Bartram C. Adult Crohn disease: Can ileoscopy replace small bowel radiology? Abdom Imaging 1998;23:117-121.
7. Acciuffl S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment Pharmacol Ther 1996; 10:321-326.
8. Goebell H, Wienbeck M, Schomerus H, Malchow H. Evaluation of the Crohn's disease activity index (CDAI) and the Dutch index for severity and activity of Crohn's disease: An analysis of the data from the European Cooperative Crohn's Disease Study. Med Klin 1990;85:573-576.
9. Andre C, Descos L, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 1981;22:571-574.
10. Andre C, Descos L, Vignal J, Gillon J. C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease. Scott Med J 1983;28:26-29.
11. Schunk K, Kern A, Heussel CP, et al. Hydro-MRT mit schnellen Sequenzen bei M. Crohn: Vergleich mit der fraktionierten MagenDarm-Passage. Fortschr Röntgenstr 1999;170:338-346.
12. Best W, Becktel J, Singleton J, Kern F. Development of a Crohn's disease activity index: National cooperative Crohn's disease study. Gastroenteiology 1976;10;439-444.
13. Bigard M, Gaucher P, Lasalle C. Fatal colonie explosion during colonoscopic polypectomy. Gastroenterology 1979;77:1307-1310.
14. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB. Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 1993;17:73-78.
15. Shoenut JP, Semelka RC, Magro CM, Silverman R, Yaffe CS, Micflikier AB. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994;19:31-35.
16. Meryn S, Lochs H, Bettelheim P, Serti K, Mulak K. Serumproteinkonzentrationen: Parameter für die Krankheitsaktivität bei Morbus Crohn? Leber Magen Darm 1985;15:160-164.
17. Lopez-Morante AJ, Saez-Royuela F, Yuguero del Moral L, Martin-Lorente JL, Ojeda-Gimenez C. The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease. Rev Esp Enferra Dig 1993;83:5-9.
18. Anderson CM, Brown JJ, Balfe DM, et al. MR imaging of Crohn disease: Use of perflubron as a gastrointestinal contrast agent. J Magn Reson Imaging 1994;4:491-496.
19. Ernst O, Asselah T, Cablan X, Sergent G. Breath-hold fast spin-echo MR imaging of Crohn's disease. AJR 1998;170:127-128.
20. Haggett PJ, Moore NR, Shearman JD, Travis SP, Jewell DP, Mortensen NJ. Pelvic and perineal complications of Crohn's disease: Assessment using magnetic resonance imaging. Gut 1995;36: 407-410.
21. Hansmann HJ, Kosa R, Düx M, et al. Hydro-MRT chronisch entzündlicher Darmerkrankungen. Fortschr Röntgenstr 1997;167: 132-138.
22. Koelbel G, Schmiedl U, Majer MC, et al. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: Value of MR imaging. AJR 1989;152:999-1003.
23. Lee JKT, Marcos H, Semelka R. MR imaging of the small bowel using the HASTE sequence. AJR 1998;170:1457-1463.
24. Madsen SM, Thomsen HS, Munkholm P, Schlichting P, Davidsen B. Magnetic resonance imaging of Crohn disease: Early recognition of treatment response and relapse. Abdom Imaging 1997;22:164-166.
25. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB. MRI in the diagnosis of Crohn's disease in two pregnant women. J Clin Gastroenterol 1993;17:244-247.